14158 Results (Page 547 of 567)
All Market Research Reports
Philippines CT Scan Market Analysis
Philippines CT Scan Market was valued at $10.14 Mn in 2023 and is predicted to grow at a CAGR of 8.37% from 2023 to 2030, to $17.80 Mn by 2030. The key drivers of this industry include the rising burden of chronic diseases, the growing population, and technological advancements. The industry is primarily dominated by GE HealthCare, Siemens Healthineers, Canon Medical Systems, and NeuroLogica Corp. among others.
Egypt Bariatric Surgery Devices Market Analysis
The Egypt Bariatric Surgery Devices Market was valued at $7.5 Mn in 2023 and is projected to grow at a CAGR of 6.7% from 2023 to 2023, to $11.7 Mn by 2030. Major factors driving the market for bariatric surgical devices include the rising incidence of adult obesity brought on by altered lifestyle patterns and excessive calorie consumption. The demand for bariatric operations is also anticipated to rise over the forecast period due to increased government backing and growing public awareness of the market's unhealthy food and beverage offerings and how they affect BMI, thus driving the market growth of the Bariatric Surgery Devices. The prominent players in the market are Baxter, Cook Medical, Medtronic, Johnson & Johnson among others.
Indonesia Lipid Disorder Therapeutics Market Analysis
Indonesia Lipid Disorder Therapeutics Market was valued at $369.7 Mn in 2023 and is predicted to grow at a CAGR of 10.83% from 2023 to 2030, to $759.3 Mn by 2030. Indonesia Lipid Disorder Therapeutics Market is growing due to Shifting Demographics, Growing Awareness, and Increasing Healthcare Expenditure. The industry is primarily dominated by players such as Sanofi, Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., AbbVie Inc., Viatris, AstraZeneca PLC, and Dr. Reddys Laboratories Ltd.
Spain Cough Hypersensitivity Syndrome Therapeutics Market Analysis
The Spain Cough Hypersensitivity Syndrome Therapeutics Market was valued at $156 Mn in 2022 and is predicted to grow at a CAGR of 4.9% from 2023 to 2030, to $229 Mn by 2030. The key drivers of this industry include the surge in the prevalence of Cough Hypersensitivity Syndrome, the emergence of advanced therapeutics, and the growing focus on patient-centered outcomes. The industry is primarily dominated by players such as Roche, Pfizer, Wyeth, Novartis, Johnson & Johnson, and Takeda among others.
Spain Mental Health Apps Market Analysis
The Spain Mental Health Apps Market was valued at $119.66 Mn in 2023 and is predicted to grow at a CAGR of 14.2% from 2023 to 2030, to $303.12 Mn by 2030. The key drivers of this industry include rising awareness, increasing smartphone penetration, and advancement in technology. The industry is primarily dominated by players such as Headspace, Calm, Happify, and 7 Cups among others.
Singapore CT Scan Market Analysis
Singapore CT Scan Market was valued at $5.53 Mn in 2023 and is predicted to grow at a CAGR of 8.47% from 2023 to 2030, to $9.77 Mn by 2030. The key drivers of this industry include rising affluence and healthcare expenditure, the growing burden of chronic diseases, and the aging population. The industry is primarily dominated by GE HealthCare, Siemens Healthineers, Canon Medical Systems, and NeuroLogica Corp. among others.
Kenya Bariatric Surgery Devices Market Analysis
The Kenya Bariatric Surgery Devices Marketwas valued at $1.9 Mn in 2023 and is projected to grow at a CAGR of 6.3% from 2023 to 2023, to $2.9 Mn by 2030. The market for bariatric surgical devices is being driven primarily by increased adult obesity rates, which are a result of changing lifestyles and consuming excessive amounts of calories. Over the course of the projection period, it is also expected that the demand for bariatric operations will increase as a result of growing public awareness of the harmful food and beverage options available in the market and how they affect body mass index (BMI), which will fuel the expansion of the bariatric surgery devices market. The prominent players in the market are Medtronic, B. Braun, Asenus Surgical, Johnson & Johnson, Cousin Surgery among others.
Japan Lipid Disorder Therapeutics Market Analysis
The Japan Lipid Disorder Therapeutics Market was valued at $277.8 Mn in 2023 and is predicted to grow at a CAGR of 11.63% from 2023 to 2030, to $600 Mn by 2030. Japan Lipid Disorder Therapeutics Market is growing due to the Rising Prevalence of Cardiovascular Disease, Growing Awareness, and Government Initiatives, and Technological Advancements. The industry is primarily dominated by players such as Sanofi, Sun Pharmaceutical Industries Ltd.Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, AbbVie Inc., Viatris, AstraZeneca PLC, and Dr. Reddys Laboratories Ltd.
UAE Cough Hypersensitivity Syndrome Therapeutics Market Analysis
The UAE Cough Hypersensitivity Syndrome Therapeutics Market was valued at $41 Mn in 2022 and is predicted to grow at a CAGR of 6.9% from 2023 to 2030, to $69 Mn by 2030. The key drivers of this industry include the rising prevalence of Cough Hypersensitivity Syndrome, supportive government initiatives, and the development of novel therapeutics. The industry is primarily dominated by players such as Sanofi, Pfizer, Akorn, Novartis, Johnson & Johnson, and GSK among others.
UK Mental Health Apps Market Analysis
The UK Mental Health Apps Market was valued at $161.2 Mn in 2023 and is predicted to grow at a CAGR of 13.2% from 2023 to 2030, to $383.96 Mn by 2030. The key drivers of this industry include reduced stigma, increasing smartphone penetration, and advancement in technology. The industry is primarily dominated by players such as Headspace, Calm, Happify, and Unmind among others.
Vietnam CT Scan Market Analysis
Vietnam CT Scan Market was valued at $23.05 Mn in 2023 and is predicted to grow at a CAGR of 8.1% from 2023 to 2030, to $39.76 Mn by 2030. The key drivers of this industry include the rising burden of chronic diseases, increasing healthcare expenditure, an aging population, and technological advancements. The industry is primarily dominated by GE HealthCare, Siemens Healthineers, Canon Medical Systems, and NeuroLogica Corp. among others.
South Africa Bariatric Surgery Devices Market Analysis
The South Africa Bariatric Surgery Devices Marketwas valued at $17.3 Mn in 2023 and is projected to grow at a CAGR of 6.43% from 2023 to 2023, to $26.8 Mn by 2030. The market for bariatric surgical devices is being driven primarily by increased adult obesity rates, which are a result of changing lifestyles and consuming excessive amounts of calories. Over the course of the projection period, it is also expected that the demand for bariatric operations will increase as a result of growing public awareness of the harmful food and beverage options available in the market and how they affect body mass index (BMI), which will fuel the expansion of the bariatric surgery devices market. The prominent players in the market are Apollo Endosurgery, Medtronic, ReShape Lifesciences, Johnson & Johnson, Cousin Biotech among others.
Malaysia Lipid Disorder Therapeutics Market Analysis
The Malaysia Lipid Disorder Therapeutics Market was valued at $194.9 Mn in 2023 and is predicted to grow at a CAGR of 11.63% from 2023 to 2030, to $421.1 Mn by 2030. Malaysia Lipid Disorder Therapeutics Market is growing due to Sedentary Lifestyles, Public Awareness and Early Intervention, Innovation, and New Treatment Options. The industry is primarily dominated by players such as Pharmaniaga Berhad, Sanofi, Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., AbbVie Inc., Viatris, AstraZeneca PLC, and Dr. Reddys Laboratories Ltd.
UK Cough Hypersensitivity Syndrome Therapeutics Market Analysis
The UK Cough Hypersensitivity Syndrome Therapeutics Market was valued at $211 Mn in 2022 and is predicted to grow at a CAGR of 3.9% from 2023 to 2030, to $286 Mn by 2030. The key drivers of this industry include the rising prevalence of Cough Hypersensitivity Syndrome, the evolving treatment landscape, and supportive regulatory policies. The industry is primarily dominated by players such as Johnson & Johnson, GSK, Merck, Novartis, AstraZeneca, and Pfizer among others.
China Mental Health Apps Market Analysis
The China Mental Health Apps Market was valued at $498.4 Mn in 2023 and is predicted to grow at a CAGR of 16.7% from 2023 to 2030, to $1469.18 Mn by 2030. The key drivers of this industry include increasing smartphone penetration, government support, and rising incidences. The industry is primarily dominated by players such as Happify, HeadSpace, Pacifica, and Now Meditation among others.
Egypt CT Scan Market Analysis
Egypt CT Scan Market was valued at $12.91 Mn in 2023 and is predicted to grow at a CAGR of 9.37% from 2023 to 2030, to $24.16 Mn by 2030. The key drivers of this industry include the rising burden of chronic diseases, increasing healthcare expenditure, an aging population, and technological advancements. The industry is primarily dominated by GE HealthCare, Siemens Healthineers, Canon Medical Systems, and NeuroLogica Corp. among others.
India Bariatric Surgery Devices Market Analysis
The India Bariatric Surgery Devices Market was valued at $48 Mn in 2023 and is projected to grow at a CAGR of 8.2% from 2023 to 2023, to $84 Mn by 2030. Major factors driving the market for bariatric surgical devices include the rising incidence of adult obesity brought on by altered lifestyle patterns and excessive calorie consumption. The demand for bariatric operations is also anticipated to rise over the forecast period due to increased government backing and growing public awareness of the market's unhealthy food and beverage offerings and how they affect BMI, thus driving the market growth of the Bariatric Surgery Devices. The prominent players in the market are Meril Life Sciences, Poly Medicure, Biopore Surgicals, Medtronic, B. Braun, Asenus Surgical, Johnson & Johnson, Cousin Surgery among others.
Singapore Lipid Disorder Therapeutics Market Analysis
The Singapore Lipid Disorder Therapeutics Market was valued at $171.7 Mn in 2023 and is predicted to grow at a CAGR of 14.13% from 2023 to 2030, to $433.1 Mn by 2030. Singapore Lipid Disorder Therapeutics Market is growing due to the Prevalence of Cardiovascular Diseases, Growing Awareness, and Advancements in Therapeutics. The industry is primarily dominated by players such as Sanofi, GlaxoSmithKline plc, Pfizer, Inc., Novartis AG, Merck & Co., Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., AbbVie Inc., Viatris, AstraZeneca PLC, and Dr. Reddys Laboratories Ltd.
US Cough Hypersensitivity Syndrome Therapeutics Market Analysis
The US Cough Hypersensitivity Syndrome Therapeutics Market was valued at $3.402 Bn in 2022 and is predicted to grow at a CAGR of 3.9% from 2023 to 2030, to $4.620 Bn by 2030. The primary factors propelling this industry comprise the rising prevalence of Cough Hypersensitivity Syndrome, growing awareness, and high unmet medical needs. The industry is primarily dominated by players such as Teva, Pfizer, Vertex, Novartis, Johnson & Johnson, and GSK among others.
Indonesia Mental Health Apps Market Analysis
The Indonesia Mental Health Apps Market was valued at $37.2 Mn in 2023 and is predicted to grow at a CAGR of 15.2% from 2023 to 2030, to $100.16 Mn by 2030. The key drivers of this industry include increasing smartphone penetration, rising incidences, and a shortage of health workers. The industry is primarily dominated by players such as HeadSpace, Calm, Happify, and Teduh among others.
South Africa CT Scan Market Analysis
South Africa CT Scan Market was valued at $29.97 Mn in 2023 and is predicted to grow at a CAGR of 9.1% from 2023 to 2030, to $55.13 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, the growing population, and increased healthcare spending. The industry is primarily dominated by GE HealthCare, Siemens Healthineers, Canon Medical Systems, and Koninklijke Philips, among others.
Saudi Arabia Bio-Implant Market Analysis
The Saudi Arabia Bio-implant Market was valued at $1105 Mn in 2023 and is predicted to grow at a CAGR of 7.4% from 2023 to 2030, to $1821.3 Mn by 2030. The Saudi Arabia Bio-implant Market is growing due to Rising Medical Tourism, Growing Awareness and Acceptance, and Government Healthcare Initiatives. The market is primarily dominated by players such as Cochlear Ltd. Edwards Lifesciences Corporation, Berlin Heart, Medtronic, Jarvik Heart Inc., Abiomed, Zimmer Biomet, Boston Scientific Corporation, Otto Bock Holding GmbH & Co. KG, and Medtronic plc.
Philippines Lipid Disorder Therapeutics Market Analysis
The Philippines Lipid Disorder Therapeutics Market was valued at $50.5 Mn in 2023 and is predicted to grow at a CAGR of 13.63% from 2023 to 2030, to $123.5 Mn by 2030. Philippines Lipid Disorder Therapeutics Market is growing due to the Rising Prevalence of Cardiovascular Diseases, Growing Awareness, Government Initiatives, and funding. The industry is primarily dominated by players such as Sanofi, Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., AbbVie Inc., Viatris, AstraZeneca PLC, and Dr. Reddys Laboratories Ltd.
Brazil Constipation Therapeutics Market Analysis
Brazil Constipation Therapeutics Market was valued at $455 Mn in 2022 and is estimated to reach $811 Mn in 2030, exhibiting a CAGR of 7.5% during the forecast period. The constipation therapeutics market is growing driven by the global rise in constipation prevalence associated with aging, sedentary lifestyles, and poor dietary habits, and further fuelled by an expanding elderly population more prone to chronic conditions. Key players in this industry include AbbVie, Allergan, Boehringer Ingelheim, EMS, Farmoquímica, Grünenthal, Johnson & Johnson, Norgine, Pfizer, and Sanofi.
Kenya CT Scan Market Analysis
Kenya CT Scan Market was valued at $3.23 Mn in 2023 and is predicted to grow at a CAGR of 8.97% from 2023 to 2030, to $5.89 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, technological advancements, growing need for early diagnosis. The industry is primarily dominated by GE HealthCare, Siemens Healthineers, Canon Medical Systems, and Koninklijke Philips, among others.
